TABLE 1

Baseline Characteristics of DTC Patients with Paired Measurements Included for Final Analyses and All Patients Initially Included

CharacteristicPatients with paired measurements (n = 67)All included patients (n = 75)
Mean age ± SD (y)47.7 ± 17.148.6 ± 17.2
Female sex (n)42 (62.7)46 (61.3)
Histology (n)
 Papillary54 (80.6)58 (77.3)
 Follicular7 (10.4)10 (13.3)
 Hürthle6 (9.0)7 (9.3)
TNM tumor stage (n)
 T stage
  Tx-T241 (61.2)45 (60.0)
  T321 (31.3)25 (33.3)
  T45 (7.5)5 (6.7)
 N stage
  Nx-N030 (44.8)38 (50.7)
  N137 (55.2)37 (49.3)
 M stage
  Mx-M064 (95.5)72 (96.0)
  M13 (4.5)3 (4.0)
Medications used   at first study visit (n)
 Oral β-blockers7 (10.4)7 (9.3)
 Diuretics8 (11.9)9 (12.0)
 Neuropsychiatric   drugs8 (11.9)10 (13.3)
 Any ≥ 4 medications23 (34.3)26 (34.7)
Comorbidity (n)
 Diabetes mellitus*4 (6.0)5 (6.7)
 Hypertension*16 (23.9)18 (24.0)
 Systemic diseases2 (3.0)2 (2.7)
  • * Defined as documented treatment for these conditions.

  • Both patients had fibromyalgia.

  • Data in parentheses are percentages.